interpret
find
support
exist
subclin
nonpneumon
sarscov
infect
infect
common
sarscov
pneumonia
local
background
although
genom
sever
acut
respiratori
syndrom
coronaviru
sarscov
sequenc
possibl
anim
reservoir
identifi
seropreval
studi
mass
screen
detect
subclin
nonpneumon
infect
still
lack
method
clone
purifi
nucleocapsid
protein
spike
polypeptid
sarscov
examin
immunogen
serum
patient
sarscov
pneumonia
elisa
base
recombin
nucleocapsid
protein
igg
detect
test
serum
healthi
blood
donor
donat
year
previous
serum
posit
antibodi
sarscov
indirect
immunofluoresc
assay
patient
sarscov
pneumonia
seropreval
sarscov
studi
elisa
healthi
blood
donor
donat
sar
outbreak
hong
kong
nonpneumon
hospit
inpati
symptomfre
healthcar
worker
posit
sampl
confirm
two
separ
westernblot
assay
recombin
nucleocapsid
protein
recombin
spike
polypeptid
find
westernblot
analysi
show
nucleocapsid
protein
spike
polypeptid
sarscov
highli
immunogen
specif
igg
antibodi
test
elisa
posit
sampl
confirm
two
westernblot
assay
sensit
three
healthi
blood
donor
donat
sar
outbreak
one
nonpneumon
paediatr
inpati
posit
igg
antibodi
confirm
two
westernblot
assay
total
studi
popul
sever
acut
respiratori
syndrom
sar
affect
countri
five
contin
case
death
novel
viru
sar
coronaviru
sarscov
known
aetiolog
agent
viral
genom
complet
sequenc
also
report
isol
virus
resembl
sarscov
himalayan
palm
civet
found
live
anim
market
guangdong
provinc
china
find
impli
anim
could
reservoir
viru
detect
sarscov
nonpneumon
case
singapor
http
suggest
nonpneumon
subclin
sarscov
infect
possibl
howev
extens
seropreval
studi
mass
screen
detect
subclin
nonpneumon
infect
still
lack
present
wide
use
method
detect
antibodi
sarscov
indirect
immunofluoresc
assay
elisa
cellcultur
extract
howev
antibodi
detect
method
difficult
standardis
compar
recombinantantigenbas
antibodydetect
test
recent
seropreval
studi
use
indirect
immunofluoresc
assay
antibodi
detect
detect
sarscov
antibodi
healthcar
worker
hospit
sar
outbreak
occur
approach
elisabas
antibodydetect
test
use
recombin
antigen
posit
result
confirm
westernblot
assay
use
two
differ
antigen
protein
offer
higher
sensit
specif
reproduc
indirect
immunofluoresc
assay
elisa
cellcultur
extract
easier
standardis
studi
use
sensit
specif
elisa
base
highli
immunogen
nucleocapsid
protein
sarscov
confirm
posit
result
westernblot
assay
recombin
nucleocapsid
protein
recombin
spike
polypeptid
anoth
highli
immunogen
protein
sarscov
examin
seropreval
nonpneumon
sarscov
gener
popul
nonpneumon
patient
hospit
healthcar
worker
sar
epidem
pellet
resuspend
l
dnasefre
rnasefre
doubledistil
water
use
templat
rtpcr
clone
purif
tag
recombin
protein
produc
fusion
plasmid
nucleocapsid
protein
sarscov
protein
purif
primer
panel
use
amplifi
gene
encod
protein
rtpcr
sequenc
code
aminoacid
residu
nucleocapsid
protein
amplifi
clone
bamhi
ecori
site
express
vector
novagen
madison
wi
usa
frame
downstream
seri
six
histidin
residu
tag
recombin
nucleocapsid
protein
express
purifi
mean
nickelload
hitrap
chelat
system
amersham
pharmacia
piscataway
nj
usa
accord
manufactur
instruct
roughli
mg
purifi
protein
routin
obtain
l
escherichia
coli
carri
fusion
plasmid
spike
protein
sarscov
primer
panel
use
amplifi
gene
encod
aminoacid
residu
rtpcr
portion
spike
protein
use
complet
protein
could
express
e
coli
pcr
product
clone
bamhi
kpni
site
vector
qiagen
hilden
germani
result
clone
digest
psti
fragment
contain
gene
encod
aminoacid
residu
spike
protein
clone
express
vector
qiagen
hilden
germani
frame
downstream
seri
six
histidin
residu
express
purif
tag
recombin
spike
polypeptid
done
describ
nucleocapsid
protein
westernblot
analysi
done
accord
publish
protocol
slight
modif
briefli
ng
purifi
tag
recombin
nucleocapsid
protein
tag
recombin
spike
polypeptid
load
well
sodium
dodecyl
sulphat
polyacrylamid
gel
electroblot
onto
nitrocellulos
membran
biorad
hercul
ca
usa
blot
cut
strip
strip
incub
separ
dilut
three
serum
sampl
obtain
three
patient
sarscov
pneumonia
posit
antibodi
sarscov
detect
indirect
immunofluoresc
assay
antigenantibodi
interact
detect
ecl
fluoresc
system
amersham
life
scienc
buckinghamshir
uk
serum
sampl
three
healthi
blood
donor
use
control
assess
recombin
nucleocapsid
protein
elisa
serum
sampl
healthi
blood
donor
donat
blood
year
previous
age
year
older
patient
pneumonia
posit
antibodi
sarscov
detect
indirect
immunofluoresc
assay
use
assess
elisabas
igg
antibodi
test
test
modifi
previou
public
briefli
well
nunc
immunopl
roskild
denmark
coat
ng
purifi
tag
recombin
nucleocapsid
protein
h
block
phosphatebuff
salin
bovin
serum
albumin
l
dilut
human
serum
ad
well
proteinco
plate
incub
h
five
wash
wash
buffer
l
horseradishperoxidaseconjug
goat
antibodi
human
igg
dilut
zyme
laboratori
inc
south
san
francisco
ca
usa
ad
well
plate
incub
h
five
wash
wash
buffer
l
dilut
zyme
laboratori
ad
well
incub
room
temperatur
min
l
moll
sulphur
acid
ad
absorb
nm
well
measur
sampl
test
duplic
mean
absorb
sampl
calcul
presenc
specif
antibodi
posit
sampl
confirm
retest
sampl
elisa
base
recombin
nucleocapsid
protein
westernblot
assay
recombin
nucleocapsid
protein
recombin
spike
polypeptid
separ
use
protocol
describ
test
presenc
igg
antibodi
nucleocapsid
protein
serum
sampl
healthi
blood
donor
age
year
older
donat
blood
marchmay
nonpneumon
paediatr
inpati
age
less
year
nonpneumon
adult
inpati
age
year
older
admit
queen
mari
hospit
may
symptomfre
healthcar
worker
presenc
specif
antibodi
posit
sampl
confirm
two
separ
westernblot
assay
one
recombin
nucleocapsid
protein
recombin
spike
polypeptid
antigen
studi
sponsor
role
studi
design
collect
analysi
interpret
data
write
report
purifi
tag
recombin
nucleocapsid
protein
spike
polypeptid
separ
denatur
polyacrylamid
gel
follow
westernblot
analysi
serum
three
patient
pneumonia
posit
antibodi
sarscov
promin
immunoreact
protein
band
kda
visibl
western
blot
use
either
antigen
figur
size
consist
expect
size
kda
fulllength
tag
nucleocapsid
protein
kda
tag
spike
polypeptid
elisabas
sarscov
antibodi
test
develop
detect
specif
antibodi
tag
recombin
nucleocapsid
protein
box
titrat
carri
differ
dilut
recombin
nucleocapsid
protein
coat
antigen
pool
serum
three
patient
pneumonia
posit
antibodi
sarscov
result
identifi
ng
purifi
tag
recombin
nucleocapsid
protein
per
elisa
well
ideal
amount
plate
coat
igg
detect
data
shown
establish
baselin
test
serum
sampl
healthi
blood
donor
donat
blood
year
previous
test
elisa
sampl
mean
optic
densiti
nm
igg
detect
sd
absorb
valu
select
cutoff
valu
mean
valu
healthi
control
plu
sd
figur
seven
sampl
healthi
blood
donor
valu
igg
elisa
figur
none
specif
antibodi
test
nucleocapsid
protein
spike
polypeptid
westernblot
assay
specif
igg
antibodi
test
elisa
confirm
westernblot
assay
mean
valu
sampl
obtain
patient
sarscov
pneumonia
posit
igg
antibodi
sarscov
indirect
immunofluoresc
assay
sd
sampl
optic
densiti
igg
elisa
figur
confirm
specif
antibodi
nucleocapsid
protein
spike
polypeptid
westernblot
assay
sensit
igg
antibodi
test
immunofluoresc
assay
gold
standard
therefor
healthi
blood
donor
donat
blood
marchmay
eight
nonpneumon
paediatr
patient
eight
nonpneumon
adult
patient
one
symptomfre
healthcar
worker
care
patient
sarscov
pneumonia
posit
igg
antibodi
elisa
figur
howev
three
healthi
blood
donor
donat
blood
marchmay
one
nonpneumon
paediatr
patient
confirm
specif
sarscov
antibodi
nucleocapsid
protein
spike
polypeptid
westernblot
assay
end
may
patient
popul
seven
million
hong
kong
develop
sarscov
pneumonia
compar
rate
nonpneumon
sarscov
infect
studi
popul
p
poisson
exact
test
equal
previou
studi
anim
coronavirus
infecti
bronchiti
viru
shown
nucleocapsid
protein
spike
protein
highli
immunogen
abundantli
express
infect
use
serodiagnosi
anim
coronaviru
infect
studi
detect
igg
antibodi
protein
highli
sensit
specif
sarscov
infect
six
serum
sampl
seroposit
immunofluoresc
assay
neg
elisa
reason
discrep
may
nucleocapsid
protein
elicit
antibodi
respons
minor
group
patient
convers
five
patient
sarscov
pneumonia
seroneg
immunofluoresc
assay
rtpcr
posit
sarscov
two
seroposit
elisa
clearli
posit
opticaldens
valu
confirm
westernblot
assay
unpublish
furthermor
four
patient
sar
coronaviru
pneumonia
serial
serum
sampl
igg
detect
earlier
elisa
immunofluoresc
test
unpublish
anoth
studi
use
elisa
base
cellcultur
extract
five
patient
sarscov
pneumonia
posit
accord
elisa
neg
indirect
immunofluoresc
time
elisa
titr
low
find
accord
result
previou
studi
human
coronaviru
show
three
serum
sampl
posit
recombinantnucleocapsidproteinbas
western
blot
neg
immunofluoresc
six
serum
sampl
posit
immunofluoresc
neg
recombinantnucleocapsidproteinbas
western
blot
find
show
elisa
may
abl
detect
addit
case
immunofluoresc
assay
miss
potenti
sensit
elisa
igg
antibodi
detect
assess
seropreval
nonpneumon
sarscov
infect
gener
popul
hospit
popul
posit
serum
sampl
detect
elisa
confirm
two
separ
westernblot
assay
two
immunolog
unrel
antigen
spike
polypeptid
use
addit
nucleocapsid
protein
westernblot
confirm
elimin
possibl
crossreact
antibodi
nucleocapsid
protein
human
coronavirus
sarscov
howev
aminoacid
ident
nucleocapsid
protein
sarscov
human
coronavirus
respect
crossreact
pair
pair
human
coronaviru
serum
sampl
sarscov
fact
individu
igg
posit
elisa
posit
nucleocapsidproteinbas
westernblot
assay
four
posit
nucleocapsid
protein
spike
polypeptid
westernblot
assay
appar
high
rate
falseposit
nonpneumon
case
detect
recombin
nucleocapsid
protein
elisa
due
use
singl
antigen
screen
asymptomat
nonpneumon
infect
well
known
posit
predict
valu
serolog
test
much
affect
preval
infect
low
especi
clinic
incompat
case
reason
immunolog
unrel
antigen
spike
protein
use
confirm
case
detect
posit
nucleocapsidproteinbas
assay
crossreact
human
coronaviru
sarscovlik
virus
remain
import
issu
futur
studi
sarscov
serolog
three
four
individu
nonpneumon
sarscov
infect
healthi
blood
donor
one
paediatr
inpati
patient
girl
admit
hospit
may
fever
day
also
note
cough
previou
week
repeat
vomit
admiss
breath
difficulti
diarrhoea
child
histori
direct
contact
patient
sarscov
pneumonia
howev
colleagu
mother
workplac
recent
diagnos
sarscov
pneumonia
physic
examin
girl
reveal
shotti
palpabl
small
measur
cervic
lymph
node
congest
throat
chest
radiograph
normal
apart
mild
lymphopenia
lymphocyt
count
l
blood
result
normal
nasopharyng
aspir
neg
influenza
virus
parainfluenza
virus
adenoviru
respiratori
syncyti
viru
antigen
given
antipyret
treatment
discharg
next
day
subsequ
antibodi
test
show
serum
posit
igg
igm
antibodi
nucleocapsid
protein
well
igg
antibodi
spike
polypeptid
sarscov
differ
rate
nonpneumon
sarscov
infect
studi
popul
rate
sar
hong
kong
suggest
nonpneumon
infect
common
sarscov
pneumonia
may
explain
case
sarscov
pneumonia
patient
obviou
contact
patient
sar
contributor
p
c
woo
k
yuen
coprincip
investig
jointli
wrote
report
coordin
supervis
studi
k
p
lau
supervis
analysi
serolog
data
correct
report
h
w
tsoi
clone
purifi
nucleocapsid
protein
serolog
assay
k
h
chan
supervis
immunofluoresc
assay
b
h
l
wong
v
k
p
tam
serolog
assay
analys
data
x
che
clone
purifi
spike
polypeptid
c
f
tam
coordin
collect
clinic
specimen
v
c
c
cheng
f
n
hung
manag
patient
databas
wong
b
j
zheng
guan
correct
report
none
declar
